Interesting opinion, but just an uneducated opinion from where I stand here in the US.
What are your thoughts on the potential value of the IHL-42X results, particularly as they relate to the recent takeover of Inversago’s phase 1b project for USD$1 billion (Aussie $1.6 billion) by one of the largest pharmaceutical companies on the world? And incidentally Bob Clark works for NN. How many FDA drug approvals have you generated? Bob has 15 out of 15.
Equally, what are your thoughts on the psi-GAD program following MAPS Phase 3 (#2) results published in Nature today. Incidentally, Rick Doblin is a pretty big deal over here. We know MAPS very well and Rick speaks extremely highly of Paul Liknaitzky. But of course you know better because you have 7,014 posts on one of the smallest and most insignificant and irrelevant exchanges in the world.
If you’re going to be a troll then at least come up with some original, intuitive and intelligent conversation. It’s embarrassing.
IHL Price at posting:
7.7¢ Sentiment: Buy Disclosure: Held
